Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
983,925
-
Share change
-
+129,489
-
Total reported value
-
$7,378,970
-
Price per share
-
$7.50
-
Number of holders
-
11
-
Value change
-
+$971,414
-
Number of buys
-
6
-
Number of sells
-
4
Institutional Holders of Nuvectis Pharma, Inc. - COM (NVCT) as of Q4 2022
As of 31 Dec 2022 Nuvectis Pharma, Inc. - COM (NVCT) had 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 983,925 shares of stock of the company.
Largest 10 holders included SABBY MANAGEMENT, LLC, VANGUARD GROUP INC, BALDWIN BROTHERS LLC/MA, GEODE CAPITAL MANAGEMENT, LLC, Virtu Financial LLC, STATE STREET CORP, BlackRock Inc., Tower Research Capital LLC (TRC), MORGAN STANLEY, and WELLS FARGO & COMPANY/MN.
This table shows 11 institutional shareholders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.